• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Fisher & Paykel launch 2 new products, see shares rise

Fisher & Paykel launch 2 new products, see shares rise

October 13, 2015 By Fink Densford

Fisher & PaykelFisher & Paykel (NZE:FPH) said today it launched a new Eson 2 Nasal mask and HumiGard SH870 surgical humidification system, sending shares up to their highest since late last month.

The Eson 2 nasal mask is designed to work with systems designed for the treatment of obstructive sleep apnea. The mask uses the comapny’s RollFit seal technology that adjusts to fit a range of face shapes and minimize pressure on the nose, Fisher & Paykel said.

“Our development team has focused on ease of use, to provide sleep professionals and patients confidence at every step from titration through to adherence. The F&P Eson has been our best performing nasal mask and has proven extremely popular with both healthcare providers and patients. We believe with the large number of design improvements the F&P Eson 2 will be even more popular,” CEO designate Lewis Gradon said in a press release.

The Eson 2 mask will be initially available in New Zealand and Australia in November with a planned European, Canadian and eventual U.S. roll-out upon attaining appropriate clearance.

“We put the patient and their needs at the centre of our mask design and, like all of our masks, the F&P Eson 2 is designed to seal comfortably, simplify use and improve treatment acceptability. Our innovative technologies have significantly advanced mask simplicity and performance, increasing the chance of long-term therapy success and, ultimately, improving patient care and outcomes,” Gradon said.

The company’s HumiGard SH870 surgical humidification system is designed to deliver warm, humidified CO2 during open and laprascopic surgeries, the company said.

“In recent years the focus of surgical humidification has been on its use during laparoscopic surgery, however mounting clinical evidence has demonstrated significant patient benefits such as improved perioperative hypothermia when utilised during open surgery. We believe that this new HumiGard system will facilitate accelerated growth in the uptake of surgical humidification by hospitals in a number of our key markets,” Gradon said.

The HumiGard will be rolled-out in New Zealand, Australia and the U.K. in November and other European markets in January, the company said.

Fisher & Paykel shares rose as high as 3.7% on the New Zealand market, their highest since September 29, and are ranked among the top percentage gainers on its SciTex Index and S&P NZX 50 Capital Index.  Shares on the Australian market rose as much as 3%, its highest since Sept 28.

Filed Under: Business/Financial News, Respiratory Tagged With: Fisher & Paykel Healthcare

In case you missed it

  • Moderna details ‘proactive’ strategy to fight emerging COVID-19 variants  
  • Surmodics’ DCB shown non-inferior to Medtronic’s In.Pact Admiral
  • Longeviti Neuro Solutions ClearFit implant wins FDA clearance for use in ultrasound
  • Medical Alley startups raise $1.4B
  • Johnson & Johnson pharma sales drive Street-beating Q4 results
  • Abbott Panbio rapid antigen test wins CE mark for asymptomatic COVID-19 screening
  • Orthospin wins FDA clearance for robotic external fixation system
  • 3M ticks up on Street-beating Q4, strong healthcare performance
  • Butterfly Network names new CEO before going public via merger
  • Authorities investigating death of California recipient of COVID-19 vaccine
  • FDA clears Aerobiotix system to clean air inside hospitals
  • Inogen names new CEO
  • FDA clears Theranica device for adolescent migraines
  • J&J touts results of robotic bronchoscopy trial
  • AdvaMed wants input on Biden pandemic DPA use
  • How continuous glucose monitors have transformed the diabetes landscape
  • Silk Road Medical issues voluntary recall of Enroute transcarotid stent system

RSS From Medical Design & Outsourcing

  • Freudenberg Medical expands U.S. molding operations
    Freudenberg Medical announced that it has expanded injection molding operations at its Baldwin Park, Calif., operation, which is focused on thermoplastics. Freudenberg Medical Baldwin Park has added six injection molding machines including three new Arburg molding machines, a work cell for two-shot molding and a Wittmann Battenfeld micro-molding machine with in-process visual inspection capability. The… […]
  • Cretex Companies names new CEO
    Cretex Companies has announced the retirement of CEO Lynn Schuler effective January 31, 2021. Schuler will be succeeded as CEO by company president and COO Jeff Wollerman. Schuler has been with Cretex Companies for 36 years and held numerous leadership positions, including six years as a business unit president and two years as CFO. Schuler… […]
  • How continuous glucose monitors have transformed the diabetes landscape
    Continuous glucose monitors (CGMs) are among the most potent diabetes management tools to emerge in recent decades. FDA approved the first professional CGM in 1999, and the technology has evolved swiftly since then. Current models beam data via Bluetooth to smartphones (plus the Apple Watch) and the cloud, enabling patients to explore their blood glucose… […]
  • FDA clears Theranica device for adolescent migraines
    Theranica announced today that the FDA has granted expanded clearance for the use of its Nerivio acute migraine treatment device by people 12 years and older. The use of the device in the treatment of adolescents is supported by a study recently published in Headache. According to the study, 28 of 39 (71%) of the… […]
  • Alleviant Medical wins FDA breakthrough device designation for transcath heart failure treatment
    Alleviant Medical (Austin, Texas) has received FDA breakthrough device designation for its no-implant, interatrial shunt technology for treating certain types of chronic heart failure. Founded in 2017, Alleviant’s minimally invasive transcatheter tech decompresses the left atrium without a permanent cardiac implant or open-heart surgery. Alleviant developed the teach to treat people who have heart failure […]
  • AdvaMed wants input on Biden pandemic DPA use
    AdvaMed reacted to President Joe Biden’s plan to use the Defense Production Act (DPA) to tackle the pandemic with some cautionary words. In a letter responding to Biden’s 200-page COVID-19 plan, the medtech trade group asked for collaboration and urged the president to consider the industry’s experience with DPA orders issued by former President Trump.… […]
  • January 2021 Issue: The Leadership in Medical Technology Issue
    9 lessons in crisis management from Stryker CEO Kevin Lobo These 10 stories mattered the most for medtech in 2020 How ResMed is advancing sleep and respiratory care How Dexcom CEO Kevin Sayer is leading the company forward Black engineers group works to promote diversity in medtech, equity in healthcare Taking the guesswork out of… […]
  • Olympus recalls thousands of endo devices due to packaging defect
    Olympus is recalling approximately 26,000 disposable EndoTherapy devices because of a packaging defect that could compromise their sterility. The announcement affects113 models distributed in the U.S.since early 2019, with different numbers of SKUs available in different regions worldwide. The company is asking customers to quarantine the devices until they can be shipped back to Olympus.… […]
  • FDA says to limit mask decontamination to 4 cycles
    Soon after healthcare workers began warning of personal protective equipment (PPE) shortages, companies and other organizations started claiming their decontamination systems could reprocess used filtering facepiece respirators (FFRs) such as N95s up to 20 times. The FDA began issuing emergency use authorizations (EUAs) for FFR decontamination systems with a range of allowable cycles and major… […]
  • 5 innovations to make duodenoscopes more single-use — and save lives
    Duodenoscopes are important medical devices that are used for endoscopic retrograde cholangiopancreatography (ERCP) procedures. However, the devices have had serious problems in the past. Luckily, several medical device companies have stepped in to solve the problems. Duodenoscopes are flexible, lighted tubes threaded through the mouth, throat and stomach into the top of the small intestine.… […]
  • Plastic Molding Manufacturing adds 5 molding machines
    Plastic Molding Manufacturing (Hudson, Mass.) announced that it has added five new injection molding and two coordinate measuring machines in upgrades to its manufacturing and quality operations. The $1 million-plus investment will enable the custom molding company to distribute the pair of 214-ton machines, two 259-ton machines, and a 101-ton machine throughout its manufacturing network,… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS